Cervical cancer is considered a threat to global public health and disproportionally affects people living with HIV. The World Health Organization has aimed to reduce the burden of cervical cancer worldwide. Because of this goal, the National Cancer Institute has created the CASCADE Network, a network with four main pillars to aid in reducing the burden cervical cancer has on women living with HIV, by targeting HPV screening as persistent HPV infections increase the risk of cervical cancer. Weill Cornell Medical College is a research base that has joined the CASCADE Network to develop studies to assist the network in achieving its goals. Our research base conducted and analyzed clinical site interviews, site surveys, and a review of current literature to develop a research protocol. From this, we found that the clinical sites must enhance their HPV screening methods and clinic capabilities to significantly lower the burden cervical cancer plays. A proposed protocol was developed for a mixed-methods study to examine the implementation and potential impact of HPV DNA testing for cervical cancer screening in resource-constrained settings. This proposed protocol will act as a framework for future studies to address the limitations of cervical cancer screening in low-resource areas. This paper describes the protocol development for a CASCADE research base housed within Weill Cornell Medical College.
| Identifer | oai:union.ndltd.org:bu.edu/oai:open.bu.edu:2144/48409 |
| Date | 15 March 2024 |
| Creators | Westerhoff, Nicolas J. |
| Contributors | Brown, Shelley, Wilkin, Timothy |
| Source Sets | Boston University |
| Language | en_US |
| Detected Language | English |
| Type | Thesis/Dissertation |
Page generated in 0.0016 seconds